These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35868251)

  • 1. Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis.
    Albertini C; Salerno A; Atzeni S; Uliassi E; Massenzio F; Maruca A; Rocca R; Mecava M; Silva FSG; Mena D; Valente P; Duarte AI; Chavarria D; Bissaro M; Moro S; Federico S; Spalluto G; Soukup O; Borges F; Alcaro S; Monti B; Oliveira PJ; Menéndez JC; Bolognesi ML
    ACS Chem Neurosci; 2022 Aug; 13(15):2252-2260. PubMed ID: 35868251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model.
    Waibel S; Reuter A; Malessa S; Blaugrund E; Ludolph AC
    J Neurol; 2004 Sep; 251(9):1080-4. PubMed ID: 15372249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
    Cheah BC; Vucic S; Krishnan AV; Kiernan MC
    Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of amyotrophic lateral sclerosis with riluzole.
    Neatherlin JS
    J Neurosci Nurs; 1998 Aug; 30(4):257-60. PubMed ID: 9791781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
    Statland JM; Moore D; Wang Y; Walsh M; Mozaffar T; Elman L; Nations SP; Mitsumoto H; Fernandes JA; Saperstein D; Hayat G; Herbelin L; Karam C; Katz J; Wilkins HM; Agbas A; Swerdlow RH; Santella RM; Dimachkie MM; Barohn RJ;
    Muscle Nerve; 2019 Feb; 59(2):201-207. PubMed ID: 30192007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
    Bellingham MC
    CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole for the treatment of amyotrophic lateral sclerosis.
    Saitoh Y; Takahashi Y
    Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis, excitotoxicity and riluzole.
    Obrenovitch TP
    Trends Pharmacol Sci; 1998 Jan; 19(1):9-11. PubMed ID: 9509893
    [No Abstract]   [Full Text] [Related]  

  • 10. A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.
    Macchi Z; Wang Y; Moore D; Katz J; Saperstein D; Walk D; Simpson E; Genge A; Bertorini T; Fernandes JA; Swenson A; Elman L; Dimachkie M; Herbelin L; Miller J; Lu J; Wilkins H; Swerdlow RH; Statland J; Barohn R;
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):345-52. PubMed ID: 25832828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
    Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I; Kaufmann P; Khan J; Simpson E; Shefner J; Levin B; Cwik V; Schoenfeld D; Aggarwal S; McDermott MP; Miller RG
    Amyotroph Lateral Scler; 2010 May; 11(3):259-65. PubMed ID: 19961263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis.
    Morren JA; Galvez-Jimenez N
    Expert Opin Investig Drugs; 2012 Mar; 21(3):297-320. PubMed ID: 22303913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I; Camu W; Hillaire-Buys D
    Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block.
    Cifra A; Nani F; Nistri A
    Eur J Neurosci; 2011 Mar; 33(5):899-913. PubMed ID: 21324003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Riluzole as a treatment for amyotrophic lateral sclerosis].
    Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A
    Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies.
    Mignani S; Majoral JP; Desaphy JF; Lentini G
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32707914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole.
    Ceccanti M; Onesti E; Rubino A; Cambieri C; Tartaglia G; Miscioscia A; Frasca V; Inghilleri M
    Brain Stimul; 2018; 11(4):775-781. PubMed ID: 29459142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiological drug therapy for amyotrophic lateral sclerosis].
    Cintas P
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.